NEUROONE MEDICAL TECHNOLOGIES Corp·4

Nov 13, 5:53 PM ET

McClurg Ronald W. 4

4 · NEUROONE MEDICAL TECHNOLOGIES Corp · Filed Nov 13, 2023

Insider Transaction Report

Form 4
Period: 2023-11-09
McClurg Ronald W.
Chief Financial Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2023-11-09+89,28389,283 total
    Exercise: $1.25Exp: 2033-11-08Common Stock (89,283 underlying)
Footnotes (1)
  • [F1]25% will vest on November 9, 2024, and the remaining 75% will vest in 36 equal monthly installments on the last day of each month following November 9, 2024.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT